Adverum Biotechnologies, Inc. (ADVM) financial statements (2020 and earlier)

Company profile

Business Address 800 SAGINAW DRIVE
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments166205190222259159
Cash and cash equivalents6615571222221159
Short-term investments10050120 38 
Receivables   10 
Deferred costs     0
Other undisclosed current assets1043210
Total current assets:176209194225261160
Noncurrent Assets
Operating lease, right-of-use asset21
Property, plant and equipment2543431
Intangible assets, net (including goodwill)  55  
Intangible assets, net (excluding goodwill)  55  
Restricted cash and investments11    
Other noncurrent assets000001
Total noncurrent assets:4758932
TOTAL ASSETS:223213202235264162
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1397544
Accounts payable422111
Accrued liabilities543111
Employee-related liabilities432322
Debt4     
Deferred rent credit 0
Restructuring reserve   01 
Deferred revenue and credits2211
Other liabilities     4
Other undisclosed current liabilities22231(3)
Total current liabilities:1911111075
Noncurrent Liabilities
Long-term debt and lease obligation28     
Operating lease, liability28
Liabilities, other than long-term debt026857
Deferred revenue and credits5757
Deferred rent credit 1
Other liabilities0000  
Other undisclosed noncurrent liabilities  11  
Total noncurrent liabilities:2827957
Total liabilities:481218191212
Stockholders' equity
Stockholders' equity attributable to parent175201184216253149
Common stock000000
Additional paid in capital561523439414337186
Accumulated other comprehensive income (loss)(1)(1)(1)(0)(0)0
Accumulated deficit(385)(321)(254)(198)(84)(37)
Total stockholders' equity:175201184216253149
TOTAL LIABILITIES AND EQUITY:223213202235264162

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues022121
Revenue, net2121
Cost of revenue
(Cost of Goods and Services Sold)
 (0)(1)(1)(0) 
Gross profit:021121
Operating expenses(69)(80)(61)(117)(50)(25)
Other undisclosed operating income 0110 
Operating loss:(69)(78)(59)(115)(48)(24)
Nonoperating income (expense)44310(1)
Debt instrument, convertible, beneficial conversion feature     2
Other nonoperating income (expense) 4310(0)
Interest and debt expense     (0)
Other undisclosed income from continuing operations before equity method investments, income taxes     0
Loss from continuing operations before income taxes:(64)(74)(56)(115)(47)(25)
Income tax benefit 1 1  
Net loss attributable to parent:(64)(73)(56)(114)(47)(25)
Preferred stock dividends and other adjustments     (3)
Net loss available to common stockholders, diluted:(64)(73)(56)(114)(47)(29)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(64)(73)(56)(114)(47)(25)
Comprehensive loss:(64)(73)(56)(114)(47)(25)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(1)0(0)(0)
Comprehensive loss, net of tax, attributable to parent:(64)(72)(57)(114)(47)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: